Department of Urology, Boston Children's Hospital, Boston, MA.
Department of Urology, Boston Medical Center, Boston, MA.
Urology. 2020 Apr;138:134-137. doi: 10.1016/j.urology.2020.01.019. Epub 2020 Jan 28.
To assess the accuracy of renal ultrasound (RUS) in detecting renal scarring (RS).
All initial DMSA scans performed from 2006 to 2009 for history of urinary tract infection (UTI) or vesicoureteral reflux (VUR) in patients under 14 years old were identified, and clinical history obtained via chart review. Patients who had RUS within 4 months of DMSA scan and no documented UTI during that interval were included. Decreased uptake of tracer associated with loss of contours or cortical thinning defined a positive DMSA study. Increased echogenicity/dysplasia, cortical thinning, atrophic kidney and/or abnormal corticomedullary differentiation defined a positive RUS. The sensitivity and specificity of RUS in identifying RS were calculated using DMSA scan as the gold standard.
A total of 144 patients had initial DMSA scans performed for UTI or VUR, with a RUS within 4 months, and no UTI between the 2 studies. Ninety-five of 144 (66%) had RS on DMSA and 49/144 (34%) did not. Patients with or without RS on DMSA were not different in gender (P = .073), age (P = .432), insurance (P = 1.000) or VUR grade (P = .132). Only 39/144 (27.1%) patients had positive RUS. The sensitivity of RUS for RS was 35.8% and the specificity was 89.8%, leading to an accuracy of 54.2% (95%CI; 45.7-62.5%, P = .999).
RUS demonstrated poor sensitivity for RS visualized on DMSA scan. This suggests that RUS is a poor screening test for RS or indicators of future renal scar. A normal ultrasound does not rule out RS or risk of future renal scar. Specificity of RUS was excellent.
评估肾脏超声(RUS)检测肾瘢痕(RS)的准确性。
确定 2006 年至 2009 年期间所有因尿路感染(UTI)或膀胱输尿管反流(VUR)病史而接受初始 DMSA 扫描的 14 岁以下患者,并通过病历回顾获取临床病史。纳入在 DMSA 扫描后 4 个月内进行 RUS 且在此期间无记录 UTI 的患者。与轮廓丢失或皮质变薄相关的示踪剂摄取减少定义为 DMSA 阳性研究。回声增强/发育不良、皮质变薄、萎缩性肾脏和/或异常皮质髓质分化定义为 RUS 阳性。使用 DMSA 扫描作为金标准,计算 RUS 识别 RS 的灵敏度和特异性。
共有 144 名患者因 UTI 或 VUR 接受初始 DMSA 扫描,在 4 个月内进行 RUS 检查,两次检查之间无 UTI。144 例患者中,95 例(66%)DMSA 上有 RS,49 例(34%)无 RS。DMSA 上有或无 RS 的患者在性别(P=0.073)、年龄(P=0.432)、保险(P=1.000)或 VUR 分级(P=0.132)方面无差异。只有 39/144(27.1%)患者 RUS 阳性。RUS 检测 RS 的灵敏度为 35.8%,特异性为 89.8%,准确率为 54.2%(95%CI:45.7-62.5%,P=0.999)。
RUS 对 DMSA 扫描显示的 RS 敏感性较差。这表明 RUS 是 RS 或未来肾瘢痕的不良筛查试验。正常的超声并不能排除 RS 或未来肾瘢痕的风险。RUS 的特异性非常好。